Quick-dissolve night tablets — water-free sublingual ritual, 30-count jar
Sublingual 30-count jar, water-free evening ritual.
- Line TriSleep™ line fact-sheet
- Audience Consumer & aging
- Technology Oral
- Dosage form Tablets
- Status Pilot-ready
Where it fits
Consumer & aging program. A water-free wind-down tablet thirty minutes before lights out.
No water, no prep — the format is built for consistency, which is the hard part of any evening program.
Sample kits in 3–5 days, pilots from 500 units, brand-side artwork supported through the OBM program.
Specifications
| Item | Value |
|---|---|
| Format | Sublingual quick-dissolve tablet |
| Count | 30 tablets / jar (sample; blister packs configurable) |
| Base | Sugar-free, neutral non-mint flavor |
| Vesicle size (NTA) | 80–150 nm |
| QC panel | NTA, TEM, endotoxin (LAL), sterility / microbial limits; batch COA |
| Storage | Material line: −20 °C up to 60 days / −80 °C up to 360 days; finished goods per program |
| Compliance (material line) | FDA DMF Type II 044197 · INCI 41316 · China national standard (drafting) |
| Typical program | Pilot from 500 units · production from 2,000 units · standard lead 15 workdays |
Specifications are indicative pending batch COA release data; final values follow the batch COA and quotation.
What's included
- 30-count tablet jar (or blister packs)
- Program guide
How to use
- Place one tablet on the tongue
- Let it dissolve fully — no water needed
- Follow the 30-day evening rhythm
Quality & compliance
- Material chain — FDA DMF Type II 044197 and INCI 41316 on the EV material line; batch COAs travel with every shipment.
- Closed line — EV material produced on the fully enclosed 0.5–5 L micro-batch platform.
- Claim discipline — routine-and-experience wording only; efficacy references stay in internal observational files with journal citations.
About the TriSleep™ line
TriSleep™ is TONGNIAN's sleep-track oral line: fermented marine-derived EVs co-formulated with plant EXOs as quick-dissolve tablets, liquids, and powder drinks on filing-friendly routes. The TriSleep™ line fact-sheet lists every dosage form, the characterization baseline and the filing status in one place; this page documents a single program from that line.
Start a pilot for Quick-dissolve night tablets — water-free sublingual ritual, 30-count jar.
Share your brand stage and target category, and we’ll return sample specs, an MOQ framework, and characterization samples (typical: sample kits in 3–5 days); to review the full-line design first, head to Knowledge · Solutions.